Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek!
Nieuwsfeed
- DAZ-Adventsrätsel – Tag 6: Halo susamen,
- #ASH20: In a multiple myeloma showdown, Regeneron marches out new PhI data for its BCMA bispecific
- CRISPR-based cure for inherited blood diseases, bispecific buzz, & a bounty of BCMA
- #ASH20: As Bristol Myers awaits FDA word, the CAR-T BCMA players go head-to-head once again. This time, they're not alone
- #ASH20: Allogene's David Chang makes the case for an off-the-shelf CAR-T in the jam packed anti-BCMA field
- #ASH20: Gilead reads out PhII data to back CAR-T player Yescarta in a new indication
- #ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
- #ASH20: David Altshuler and the Vertex/CRISPR team hit a historic milestone in the hunt for a curative gene editing approach to sickle cell disease, beta thalassemia
- Weekend reads: Google AI researcher fired after being asked to retract paper; paper “used to justify human rights violations;” a COVID-19 retraction
- Weekend reads: Google AI researcher fired after being asked to retract paper; journal accused of stonewalling on paper “used to justify human rights violations;” reflecting on a COVID-19 retraction
- Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations
- Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
- Meer coronabesmettingen
- Microtubule-targeting agents and neurodegeneration
- Extracellular vesicles in blood: are they viable as diagnostic and predictive tools in breast cancer?
- Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy
- How we can make the best use of Covid-19 vaccines
- Streamlined approval of biosimilars: moving on from the confirmatory efficacy trial
- Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials
- Pharmacology of enalapril in children: a review
- FABP5 as a novel molecular target in prostate cancer
- TrialSite News Daily Digest
- Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 and Flu Combination Test for use with home-collected samples
- UPDATED PUBLIC PARTICIPATION INFORMATION: July 14, 2020: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 07/14/2020 - 07/14/2020
- WishGarden Herbs Issues Voluntary Nationwide Recall of Cord Care and Goldenseal Powder Due to Bacterial Contamination
- DAZ-Adventsrätsel – Tag 5: Der Dichter und die Gicht
- OPDP eCTD
- Coronavirus (COVID-19) Update: December 4, 2020
- MDCG clarifies remote audit expectations for notified bodies
- The latest from Pharmalot
- FDA approves weight management drug for patients aged 12 and older
- New studies show diabetes drug not proven to improve blood sugar control in pediatric patients
- BIO to file lawsuit today to block Trump international drug pricing policy; how climate change could chip away at sleep health
- Compliance Actions (Biologics)
- Healthcare Providers (Biologics)
- The Week Ahead in the European Parliament – Friday, December 4, 2020
- Industry (Biologics)
- Register Now: Online Event on Ethics in Science
- Tissue Guidances
- Vaccine and Related Biological Product Guidances
- Antiseptic FDA Letters
- CBER Biologics Effectiveness and Safety (BEST) System
- Coronavirus (COVID-19) | CBER-Regulated Biologics
- Cleveland Clinic to help bring affordable broadband to city neighborhood
- COVID-19 therapeutics tracker
- Remarks by Dr. Hahn to the Remarks to the National Academy of Medicine Town Hall on the COVID-19 Vaccine - 12/04/2020
- Remarks by Dr. Hahn to the Remarks to the National Academy of Medicine Town Hall on the COVID-19 Vaccine - 12/04/2020
- Recon: Lilly, UnitedHealth launch COVID antibody trial; Bahrain authorizes Pfizer-BioNTech vaccine
- ARCHIVER Prototype Phase Kick-off Event
- Office of Infectious Diseases Research Activities